Abbvie Beats Street 3q Forecasts

Earnings, adjusted for non-recurring costs and amortization costs, came to $1.13 per share. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.07 per share. AbbVie expects full-year earnings in the range of $4.26 to $4.28 per share.

Topics:  zacks investment research   abbvie   earnings   share   costs   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News